Adagio Medical (ADGM) vs Nexalin Technology (NXL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Adagio Medical is the larger company by market cap ($3.5 million vs $3.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADGM | NXL |
|---|---|---|
| Share price | $0.13 | $3.63 |
| Market cap | $3.53M | $3.01M |
| 1-day change | 0.00% | -11.68% |
| EPS (TTM) | $-1.37 | $-12.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.12 | $50.70 |
| 52-week low | $0.12 | $3.50 |
| Distance from 52-week high | -93.87% | -92.84% |
| Analyst consensus | none | buy |
| Avg. price target upside | +2461.54% | +313.22% |
| Average volume | 9.22M | 1.02M |
| Shares outstanding | 27.19M | 829.40K |
| Employees | 41 | 8 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Adagio Medical
ADGM stock →Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia.
Health Care · Medical/Dental Instruments · 41 employees
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
ADGM vs NXL FAQ
Which is bigger, Adagio Medical or Nexalin Technology?
Adagio Medical (ADGM) is larger, with a market capitalization of $3.53M compared with $3.01M for Nexalin Technology (NXL).
Are Adagio Medical and Nexalin Technology in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Adagio Medical and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Nexalin Technology.